Article
Immunization with a recombinant fowlpox virus expressing a hepatitis C virus core-E1 polyprotein variant, protects mice and African green monkeys (Chlorocebus aethiops sabaeus) against challenge with a surrogate vaccinia virus.
Biotechnology and applied biochemistry - 1 Oct 2008
Alvarez-Lajonchere Liz, Amador-Cañizares Yalena, Frías Roberto, Milian Yoamel, Musacchio Alexis, Guerra Ivis, Acosta-Rivero Nelson, Martínez Gillian, Castro Jorge, Puentes Pedro, Cosme Karelia, Dueñas-Carrera Santiago
Abstract excerpt
HCV (hepatitis C virus) is a worldwide health problem nowadays. No preventive vaccine is available against this pathogen, and therapeutic treatments currently in use have important drawbacks, including limited efficacy. In the present work a recombinant fowlpox virus, FPCoE1, expressing a truncated HCV core-E1 polyprotein, was generated. FPCoE1 virus generally failed to elicit a humoral immune response against...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
